Report: North American Markets for Facial Aesthetics 2008

North American Markets for Facial Aesthetics 2008

Published by

Millennium Research Group

Published

2008/06

Content info

Product code

MRG72879

Price

From US $ 6495

PDF by E-Mail

Approx. 1-2 business days

Hard Copy/CD-ROM

Approx. 3-4 business days

If you need expedited delivery, please call us.

Abstract

The North American facial aesthetic market, including sales of botulinum toxin (BTX), hyaluronic acid (HA), particle and polymer fillers (PPFs), and collagen products in the US and Canada was worth near $800 million in 2007.

The primary driver of North American market growth was expansion within the HA market segment, fueled by the successful launch of Juvederm by Allergan into the US market in January 2007.